Blasini C, Glas K, Blasini R, Haas S, Wriedt-Lübbe I, Blümel G
Z Orthop Ihre Grenzgeb. 1981 Oct;119(5):455-62. doi: 10.1055/s-2008-1053317.
The activity of plasminogen activators and plasmin inhibitors in articular capsules of the hip and knee joints in rheumatoid arthritis, chronic traumatic inflammation, arthrosis and aseptic loosening of prosthesis was determined histochemically and correlated with the degree of mobility in osteoarthrosis of the hip. Microscopically unchanged articular capsules were employed as reference sites. In inflammatory articular diseases the plasminogen activator activity was significantly reduced, whereas it remained unchanged in arthrosis and necrosis of the heas of the femur, and significantly enhanced in aseptic loosening of prosthesis. Plasmin inhibitor activity was established in joint capsules with inflammatory changes only; in case of rheumatic inflammation, it was higher than with traumatic inflammation. In osteoarthrosis of the hip there is a positive correlation between joint mobility and plasminogen activator activity. The results point towards involvement of the local fibrinolytic system in joint diseases; however, no definite statement can be made with regard to possible causative linkups.
采用组织化学方法测定了类风湿性关节炎、慢性创伤性炎症、关节病及假体无菌性松动患者髋关节和膝关节关节囊内纤溶酶原激活剂和纤溶酶抑制剂的活性,并将其与髋关节骨关节炎的活动度进行了关联分析。将显微镜下未发生改变的关节囊作为对照部位。在炎性关节疾病中,纤溶酶原激活剂活性显著降低,而在关节病和股骨头坏死中其活性保持不变,在假体无菌性松动中则显著增强。仅在有炎症改变的关节囊中检测到纤溶酶抑制剂活性;在风湿性炎症时,其活性高于创伤性炎症。在髋关节骨关节炎中,关节活动度与纤溶酶原激活剂活性呈正相关。结果表明局部纤维蛋白溶解系统参与了关节疾病;然而,关于可能的因果联系尚无法得出明确结论。